Abstract
FRI-200 - Sofosbuvir/Velpatasvir (S/V) for the treatment of HCV infection among vulnerable inner-city residents: extending the results of clinical trial part 2
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have